相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
Simpa S. Salami et al.
BJU INTERNATIONAL (2015)
Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology
Jesse D. Le et al.
EUROPEAN UROLOGY (2015)
Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
M. Minhaj Siddiqui et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance
Annerleim Walton Diaz et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Accuracy of Multiparametric MRI for Prostate Cancer Detection: A Meta-Analysis
Maarten de Rooij et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2014)
The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men
Moniek M. Vedder et al.
EUROPEAN UROLOGY (2014)
Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
Gisele H. J. M. Leyten et al.
EUROPEAN UROLOGY (2014)
Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
John T. Wei et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies
Alan W. Partin et al.
JOURNAL OF UROLOGY (2014)
A Commentary on PSA Velocity and Doubling Time for Clinical Decisions in Prostate Cancer
Andrew J. Vickers et al.
UROLOGY (2014)
Frequent Disruption of Chromodomain Helicase DNA-Binding Protein 8 (CHD8) and Functionally Associated Chromatin Regulators in Prostate Cancer
Nathan A. Damaschke et al.
NEOPLASIA (2014)
Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy
Atsushi Ochiai et al.
BJU INTERNATIONAL (2013)
Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology
Sofie Isebaert et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)
Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy
Vincenzo Scattoni et al.
JOURNAL OF UROLOGY (2013)
Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study
Grant D. Stewart et al.
JOURNAL OF UROLOGY (2013)
Using the Epigenetic Field Defect to Detect Prostate Cancer in Biopsy Negative Patients
Matthew Truong et al.
JOURNAL OF UROLOGY (2013)
PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study
Marc C. Gittelman et al.
JOURNAL OF UROLOGY (2013)
Toward the Detection of Prostate Cancer in Urine: A Critical Analysis
Matthew Truong et al.
JOURNAL OF UROLOGY (2013)
Transition Zone Prostate Cancer: Incremental Value of Diffusion-weighted Endorectal MR Imaging in Tumor Detection and Assessment of Aggressiveness
Sung Il Jung et al.
RADIOLOGY (2013)
Transition Zone Prostate Cancer: Detection and Localization with 3-T Multiparametric MR Imaging
Caroline M. A. Hoeks et al.
RADIOLOGY (2013)
Relationship between prostate cancer gene 3 (PCA3) and characteristics of tumor aggressiveness
Herbert Augustin et al.
PROSTATE (2013)
Epigenetic Susceptibility Factors for Prostate Cancer With Aging
N. A. Damaschke et al.
PROSTATE (2013)
Prostate Cancer Gene 3 and Multiparametric Magnetic Resonance Can Reduce Unnecessary Biopsies: Decision Curve Analysis to Evaluate Predictive Models
Gian Maria Busetto et al.
UROLOGY (2013)
Methylation Profiling Defines an Extensive Field Defect in Histologically Normal Prostate Tissues Associated with Prostate Cancer
Bing Yang et al.
NEOPLASIA (2013)
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy
Marco Auprich et al.
BJU INTERNATIONAL (2012)
The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance
Hein van Poppel et al.
BJU INTERNATIONAL (2012)
Chronic prostatitis does not influence urinary PCA3 score
Virginie Vlaeminck-Guillem et al.
PROSTATE (2012)
Integrating multiparametric prostate MRI into clinical practice
A.R. Padhani
CANCER IMAGING (2012)
PCA3 Score and Prostate Cancer Diagnosis at Repeated Saturation Biopsy. Which cut-off: 20 or 35?
Pietro Pepe et al.
INTERNATIONAL BRAZ J UROL (2012)
Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging
Nicolas Barry Delongchamps et al.
BJU INTERNATIONAL (2011)
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
William J. Catalona et al.
JOURNAL OF UROLOGY (2011)
Sarcosine in Prostate Cancer Tissue is Not a Differential Metabolite for Prostate Cancer Aggressiveness and Biochemical Progression
Florian Jentzmik et al.
JOURNAL OF UROLOGY (2011)
Urinary PCA3 Score Predicts Prostate Cancer Multifocality
Virginie Vlaeminck-Guillem et al.
JOURNAL OF UROLOGY (2011)
The Effect of Dutasteride on the Usefulness of Prostate Specific Antigen for the Diagnosis of High Grade and Clinically Relevant Prostate Cancer in Men With a Previous Negative Biopsy: Results From the REDUCE Study
Gerald L. Andriole et al.
JOURNAL OF UROLOGY (2011)
TMPRSS2-ERG Gene Fusion Prevalence and Class Are Significantly Different in Prostate Cancer of Caucasian, African-American and Japanese Patients
Cristina Magi-Galluzzi et al.
PROSTATE (2011)
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Scott A. Tomlins et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols
Michael A. Liss et al.
WORLD JOURNAL OF UROLOGY (2011)
Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling
Ayman S. Moussa et al.
BJU INTERNATIONAL (2010)
Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes
Ilse Van der Auwera et al.
CANCER BIOLOGY & THERAPY (2010)
Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy
Alessandro Sciarra et al.
CLINICAL CANCER RESEARCH (2010)
External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome
Marco Auprich et al.
EUROPEAN UROLOGY (2010)
Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test
Monique J. Roobol et al.
EUROPEAN UROLOGY (2010)
Risk Factors for Prostate Cancer Detection After a Negative Biopsy: A Novel Multivariable Longitudinal Approach
Peter H. Gann et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prostate Specific Antigen Velocity Does Not Aid Prostate Cancer Detection in Men With Prior Negative Biopsy
Andrew J. Vickers et al.
JOURNAL OF UROLOGY (2010)
PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial
Sheila M. J. Aubin et al.
JOURNAL OF UROLOGY (2010)
Prostate Cancer: Differentiation of Central Gland Cancer from Benign Prostatic Hyperplasia by Using Diffusion-weighted and Dynamic Contrast-enhanced MR Imaging
Aytekin Oto et al.
RADIOLOGY (2010)
Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay
K. Robinson et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens
Jennifer Maki et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy
Anurag K. Singh et al.
BJU INTERNATIONAL (2008)
Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
Alexander Haese et al.
EUROPEAN UROLOGY (2008)
PCA3 Score Before Radical Prostatectomy Predicts Extracapsular Extension and Tumor Volume
Eric J. Whitman et al.
JOURNAL OF UROLOGY (2008)
Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade
Nelly Tan et al.
JOURNAL OF UROLOGY (2008)
A novel nomogram to predict the probability of prostate cancer on repeat biopsy
Luigi Benecchi et al.
JOURNAL OF UROLOGY (2008)
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer
Daphne Hessels et al.
CLINICAL CANCER RESEARCH (2007)
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer
Rohit Mehra et al.
MODERN PATHOLOGY (2007)
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy
Leonard S. Marks et al.
UROLOGY (2007)
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer
Bharathi Laxman et al.
NEOPLASIA (2006)
Validation of a nomogram for predicting positive repeat biopsy for prostate cancer
BV Yanke et al.
JOURNAL OF UROLOGY (2005)
A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session
E Lopez-Corona et al.
JOURNAL OF UROLOGY (2003)
The influence of finasteride on the development of prostate cancer
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol
GC Durkan et al.
BJU INTERNATIONAL (2002)
Serial biopsy results in prostate cancer screening study
KA Roehl et al.
JOURNAL OF UROLOGY (2002)
Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1,051 men
B Djavan et al.
JOURNAL OF UROLOGY (2000)
分享论文
